LI
GEVA

LMCG Investments’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

LMCG Investments’s Portfolio GEVA Stock Details GEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-56,342
Closed -$5.5M – 565
2015
Q1 		$5.5M Buy
56,342
+29,337
+109% +$3.11M 0.12% 295
2014
Q4 		$2.5M Buy
+27,005
New +$2.13M 0.05% 324

LMCG Investments's GEVA Position: Q2 2015 in Review

LMCG Investments sold out of SYNAGEVA BIOPHARMA CORP COM STK (DE) (GEVA) in Q2 2015, closing a stake of 56,342 shares — an estimated $5.5M sold.

LMCG Investments first reported a position in GEVA in Q4 2014 and held it in 2 quarters. The position peaked at $5.5M in Q1 2015. 0 funds tracked by Wall St. Rank hold GEVA as of Q2 2015.

  • LMCG Investments reported no remaining SYNAGEVA BIOPHARMA CORP COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • LMCG Investments sold 56,342 SYNAGEVA BIOPHARMA CORP COM STK (DE) shares in Q2 2015, an estimated $5.5M.
  • LMCG Investments first reported a position in SYNAGEVA BIOPHARMA CORP COM STK (DE) in Q4 2014 and held it in 2 quarters.
  • LMCG Investments's SYNAGEVA BIOPHARMA CORP COM STK (DE) position peaked at $5.5M in Q1 2015.
  • 0 funds tracked by Wall St. Rank held SYNAGEVA BIOPHARMA CORP COM STK (DE) as of Q2 2015.

Based on LMCG Investments's 13F filing for Q2 2015, filed 13 Aug 2015.